Simranjit Singh

Klinify has been providing world-class digital solutions for over 7 years to help clinics around the region to manage their clinical operations in a seamless and hassle-free way. We’re now focused on supporting clinics in Malaysia, with over 1200 doctors and 350 clinics actively using our system. We are based in Singapore, with talented employees coming from all parts of the world, making Klinify a truly multicultural, open and integrated company. Our goal is to be the leading digital service provider in the region, with plans to expand to Hong Kong, Taiwan and Indonesia in the near future.

Holmusk is a data analytics and health technology company on a mission to harness real-world evidence to transform both research and care for behavioral health. Combining a leading behavioral health database with AI-powered analytics and digital solutions designed to address the most pressing challenges in behavioral health, Holmusk is advancing the frontier of evidence generation and fueling innovation. Holmusk’s core offerings include HolCare EHR+, an electronic health records platform with built-in measurement-based care, and NeuroBlu Research, a powerful data analytics solution that enables users to build patient cohorts, explore datasets, and discover new insights. Founded in 2015, Holmusk is a global company headquartered in Singapore and New York. Holmusk was recognized as a Technology Pioneer in 2019 by the World Economic Forum.

Klinify has been providing world-class digital solutions for over 7 years to help clinics around the region to manage their clinical operations in a seamless and hassle-free way. We’re now focused on supporting clinics in Malaysia, with over 1200 doctors and 350 clinics actively using our system. We are based in Singapore, with talented employees coming from all parts of the world, making Klinify a truly multicultural, open and integrated company. Our goal is to be the leading digital service provider in the region, with plans to expand to Hong Kong, Taiwan and Indonesia in the near future.

Holmusk is a data analytics and health technology company on a mission to harness real-world evidence to transform both research and care for behavioral health. Combining a leading behavioral health database with AI-powered analytics and digital solutions designed to address the most pressing challenges in behavioral health, Holmusk is advancing the frontier of evidence generation and fueling innovation. Holmusk’s core offerings include HolCare EHR+, an electronic health records platform with built-in measurement-based care, and NeuroBlu Research, a powerful data analytics solution that enables users to build patient cohorts, explore datasets, and discover new insights. Founded in 2015, Holmusk is a global company headquartered in Singapore and New York. Holmusk was recognized as a Technology Pioneer in 2019 by the World Economic Forum.

IQVIA (NYSE:IQV) is a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. IQVIA’s portfolio of solutions are powered by IQVIA Connected Intelligence™ to deliver actionable insights and services built on high-quality health data, Healthcare-grade AI™, advanced analytics, the latest technologies and extensive domain expertise. With approximately 88,000 employees in over 100 countries, including experts in healthcare, life sciences, data science, technology and operational excellence, IQVIA is dedicated to accelerating the development and commercialization of innovative medical treatments to help improve patient outcomes and population health worldwide. IQVIA is a global leader in protecting individual patient privacy. The company uses a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with the precise treatment path and therapy needed for better outcomes. IQVIA’s insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors and scientific progress, in an effort to advance healthcare. To learn more, visit www.iqvia.com.

IMS Health has now merged with Quintiles. Visit our new website for more information www.iqvia.com